One might think that we had enough crises already without creating a new one, but apparently that’s not the case. To much fanfare, the Biden Administration unveiled its long awaited “guidelines” for agency use of the march in rights provision of the Bayh-Dole Act.
The Biden Administration has announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.
The Biden Administration on Thursday
announced it is setting new policy that will allow it to seize
patents for medicines developed with government funding if it
believes their prices are too high. .
The National Institute of Standards & Technology and the Department of Commerce today published a draft version of a Federal Register Notice seeking comments on a proposed framework for deciding whether and when to exercise march-in rights under the Bayh-Dole Act.
US sets policy to seize patents of government-funded drugs if price deemed too high yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.